206 related articles for article (PubMed ID: 33595992)
1. Caregivers' willingness to pay for Alzheimer's disease medications in Taiwan.
Huang MH; Tsai CF; Lee WJ; Wang WF; Jhang KM; Wang SJ; Fuh JL
J Chin Med Assoc; 2021 Apr; 84(4):446-452. PubMed ID: 33595992
[TBL] [Abstract][Full Text] [Related]
2. Caregivers' willingness-to-pay for Alzheimer's disease medications in Canada.
Oremus M; Tarride JE; Pullenayegum E; Clayton N; Mugford G; Godwin M; Huan A; Bacher Y; Villalpando JM; Gill SS; Lanctôt KL; Herrmann N; ; Raina P
Dementia (London); 2015 Jan; 14(1):63-79. PubMed ID: 24339090
[TBL] [Abstract][Full Text] [Related]
3. Economic analysis of the intangible impacts of informal care for people with Alzheimer's disease and other mental disorders.
Gervès C; Bellanger MM; Ankri J
Value Health; 2013; 16(5):745-54. PubMed ID: 23947967
[TBL] [Abstract][Full Text] [Related]
4. Willingness of families caring for victims of dementia to pay for nursing home care: results of a pilot study in Taiwan.
Chiu L; Tang KY; Liu YH; Shyu WC; Chang TP
J Manag Med; 1998; 12(6):349-60, 321. PubMed ID: 10351260
[TBL] [Abstract][Full Text] [Related]
5. Willingness-to-pay and willingness-to-accept of informal caregivers of dependent elderly people in Shanghai, China.
Liu W; Lyu T; Zhang X; Yuan S; Zhang H
BMC Health Serv Res; 2020 Jul; 20(1):618. PubMed ID: 32631341
[TBL] [Abstract][Full Text] [Related]
6. Caregivers' willingness to pay for digital support services: Comparative survey.
Hassan AYI; Cucculelli M; Lamura G
Health Policy; 2023 Apr; 130():104751. PubMed ID: 36857837
[TBL] [Abstract][Full Text] [Related]
7. The cost-benefit of cholinesterase inhibitors in mild to moderate dementia: a willingness-to-pay approach.
Wu G; Lanctôt KL; Herrmann N; Moosa S; Oh PI
CNS Drugs; 2003; 17(14):1045-57. PubMed ID: 14594444
[TBL] [Abstract][Full Text] [Related]
8. The general public's willingness to pay for tax increases to support unrestricted access to an Alzheimer's disease medication.
Oremus M; Tarride JE; Raina P; Thabane L; Foster G; Goldsmith CH; Clayton N
Pharmacoeconomics; 2012 Nov; 30(11):1085-95. PubMed ID: 22938161
[TBL] [Abstract][Full Text] [Related]
9. Caregivers' emotional distress due to neuropsychiatric symptoms of persons with amnestic mild cognitive impairment or Alzheimer's disease.
Mavounza C; Ouellet MC; Hudon C
Aging Ment Health; 2020 Mar; 24(3):423-430. PubMed ID: 30588847
[TBL] [Abstract][Full Text] [Related]
10. Estimating the cost of referral and willingness to pay for referral to higher-level health facilities: a case series study from an integrated community case management programme in Uganda.
Nanyonjo A; Bagorogoza B; Kasteng F; Ayebale G; Makumbi F; Tomson G; Källander K;
BMC Health Serv Res; 2015 Aug; 15():347. PubMed ID: 26315661
[TBL] [Abstract][Full Text] [Related]
11. Dementia Family Caregivers' Willingness to Pay for an In-home Program to Reduce Behavioral Symptoms and Caregiver Stress.
Jutkowitz E; Scerpella D; Pizzi LT; Marx K; Samus Q; Piersol CV; Gitlin LN
Pharmacoeconomics; 2019 Apr; 37(4):563-572. PubMed ID: 30877638
[TBL] [Abstract][Full Text] [Related]
12. Patients' willingness-to-pay for an Alzheimer's disease medication in Canada.
Oremus M; Tarride JE; Pullenayegum E; Clayton N; ; Raina P
Patient; 2013; 6(3):161-8. PubMed ID: 23716166
[TBL] [Abstract][Full Text] [Related]
13. Willingness to Pay in Caregivers of Patients Affected by Schizophrenia.
Daltio CS; Attux C; Ferraz MB
J Ment Health Policy Econ; 2017 Mar; 20(1):3-10. PubMed ID: 28418833
[TBL] [Abstract][Full Text] [Related]
14. Why would caregivers not want to treat their relative's Alzheimer's disease?
Karlawish JH; Casarett DJ; James BD; Tenhave T; Clark CM; Asch DA
J Am Geriatr Soc; 2003 Oct; 51(10):1391-7. PubMed ID: 14511158
[TBL] [Abstract][Full Text] [Related]
15. Willingness to pay for lung cancer treatment.
Lang HC
Value Health; 2010; 13(6):743-9. PubMed ID: 20561327
[TBL] [Abstract][Full Text] [Related]
16. 2022 Alzheimer's disease facts and figures.
Alzheimers Dement; 2022 Apr; 18(4):700-789. PubMed ID: 35289055
[TBL] [Abstract][Full Text] [Related]
17. Impact of Alzheimer's disease on the family caregiver's long-term quality of life: results from an ALSOVA follow-up study.
Välimäki TH; Martikainen JA; Hongisto K; Väätäinen S; Sintonen H; Koivisto AM
Qual Life Res; 2016 Mar; 25(3):687-97. PubMed ID: 26350541
[TBL] [Abstract][Full Text] [Related]
18. Determinants of the quality of life in Alzheimer's disease patients as assessed by the Japanese version of the Quality of Life-Alzheimer's disease scale.
Matsui T; Nakaaki S; Murata Y; Sato J; Shinagawa Y; Tatsumi H; Furukawa TA
Dement Geriatr Cogn Disord; 2006; 21(3):182-91. PubMed ID: 16401890
[TBL] [Abstract][Full Text] [Related]
19. The current state of family caregiver burden and support of toilet problems for elderly with mild cognitive impairment and Alzheimer's disease.
Kamiya M; Osawa A; Shinoda Y; Nishii H; Kondo I
Int J Urol; 2023 Jun; 30(6):539-546. PubMed ID: 36851841
[TBL] [Abstract][Full Text] [Related]
20. The relationship between caregivers' global ratings of Alzheimer's disease patients' quality of life, disease severity, and the caregiving experience.
Karlawish JH; Casarett D; Klocinski J; Clark CM
J Am Geriatr Soc; 2001 Aug; 49(8):1066-70. PubMed ID: 11555068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
